What is Metro Lab?
Metro Lab operates as a comprehensive, full-service diagnostic facility, providing a diverse array of testing solutions that range from clinical laboratory analysis and DNA testing to specialized drug and alcohol screening. By integrating advanced medical equipment with proprietary testing methodologies, the company serves a dual-client base consisting of individual consumers and corporate entities requiring rigorous pre-employment screening and clinical trial support. The firm's commitment to precision and quality assurance has established it as a reliable partner in the broader healthcare ecosystem, effectively bridging the gap between complex medical diagnostics and accessible public health services.
How much funding has Metro Lab raised?
Metro Lab has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Metro Lab
PPP
Public-Private Partnership
What's next for Metro Lab?
The infusion of capital is expected to accelerate Metro Lab's operational footprint, enabling the firm to modernize its laboratory facilities and expand its service portfolio to meet rising demand for rapid diagnostic testing. As the company transitions through its current growth phase, strategic priorities will likely include the adoption of next-generation testing technologies and the optimization of supply chain logistics to enhance turnaround times. By leveraging this financial backing, Metro Lab is poised to solidify its market position, potentially exploring new geographic territories and diversifying its clinical trial service offerings to drive long-term value for stakeholders.
See full Metro Lab company page
